Literature DB >> 18632784

A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble?

P Invernizzi1, M A Bonometti, E Turri, M D Benedetti, A Salviati.   

Abstract

We present the case of a 36-year-old woman affected with Fabry disease (FD), with neuroradiologic and laboratory tests suggestive of a coexistent inflammatory demyelinating disease. Since the age of 23, she presented recurrent neurologic deficits, such as right limb paresthesias, diplopia, and right leg weakness. Magnetic resonance imaging revealed multiple demyelinating lesions in periventricular areas, corpus callosum, and spinal cord. Cerebrospinal fluid analysis showed the presence of oligoclonal bands, while visual-evoked potentials were delayed with preserved morphology. FD is usually considered as a differential diagnosis of multiple sclerosis, but we think that the best explanation of all pathological features in this case is the coexistence of the two diseases.

Entities:  

Mesh:

Year:  2008        PMID: 18632784     DOI: 10.1177/1352458508092355

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  6 in total

1.  Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

Authors:  Sirio Cocozza; Gaia Olivo; Eleonora Riccio; Camilla Russo; Giuseppe Pontillo; Lorenzo Ugga; Silvia Migliaccio; Dario de Rosa; Sandro Feriozzi; Massimiliano Veroux; Yuri Battaglia; Daniela Concolino; Federico Pieruzzi; Antonino Tuttolomondo; Aurelio Caronia; Cinzia Valeria Russo; Roberta Lanzillo; Vincenzo Brescia Morra; Massimo Imbriaco; Arturo Brunetti; Enrico Tedeschi; Antonio Pisani
Journal:  Neuroradiology       Date:  2017-04-06       Impact factor: 2.804

2.  Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy.

Authors:  Alessandro Salviati; Alessandro P Burlina; Walter Borsini
Journal:  Neurol Sci       Date:  2010-03-19       Impact factor: 3.307

3.  Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene.

Authors:  Jan Lukas; Joan Torras; Itziar Navarro; Anne-Katrin Giese; Tobias Böttcher; Hermann Mascher; Karl J Lackner; Guenter Fauler; Eduard Paschke; Josep M Cruzado; Ales Dudesek; Matthias Wittstock; Wolfgang Meyer; Arndt Rolfs
Journal:  Clin Kidney J       Date:  2012-10

4.  Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?

Authors:  Tobias Böttcher; Arndt Rolfs; Christian Tanislav; Andreas Bitsch; Wolfgang Köhler; Jens Gaedeke; Anne-Katrin Giese; Edwin H Kolodny; Thomas Duning
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

5.  Case Report: A Spinal Ischemic Lesion in a 24-Year-Old Patient With Fabry Disease.

Authors:  Julia Krämer; Felix Glaser; Martin Hasselblatt; Eva Brand; Christian Pogoda; Malte Lenders; Heinz Wiendl; Sven G Meuth; Thomas Duning
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

6.  Fabry disease and multiple sclerosis misdiagnosis: the role of family history and neurological signs.

Authors:  Alessandro Burlina; Giovanni Duro; Paolo Colomba; Carmela Zizzo; Riccardo Alessandro; Giuseppe Cammarata; Simone Scalia; Antonello Giordano; Maurizio Pieroni; Luigi Sicurella; Luisa Amico
Journal:  Oncotarget       Date:  2018-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.